SEC Form 4 · accession 0001136261-18-000081
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Pina
Officer — SVP, GC & Compliance Off
Period of report
Mar 15, 2018
Accepted (ET)
Mar 16, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 15, 2018 | A | 5,000 | $0.00 | A | 16,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $2.46 | Mar 15, 2018 | A | 15,000 | A | — | Mar 14, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Represents a grant of restricted share units ("RSUs") that vest in four equal annual installments of 1,250 over a four-year period, with the first installment vesting on March 15, 2019, which is the one-year anniversary of the grant date.
- F2Consists of (i) the unvested amount of previously awarded RSUs that vest in three equal installments of 1,250 shares, with the next installment vesting on January 4, 2019, (ii) the unvested amount of previously awarded RSUs that vest in four equal installments of 1,500 shares, with the next installment vesting on August 8, 2018 and (iii) the unvested amount of the RSUs that vest as described in footnote 1 above.
- F3The stock option vests in four equal annual installments of 3,750 shares over a four-year period, with the first installment vesting at the close of business on March 15, 2019, which is the one-year anniversary of the grant date.